We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-0.47%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$38.8B
AUM Growth
+$957M
(+2.5%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4.52%
Top 10 Holdings %
Top 10 Hldgs %
18.92%
Holding
4,122
New
310
Increased
2,005
Reduced
1,517
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$140M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$87.2M |
| 3 |
CMCT
Creative Media & Community Trust
CMCT
|
+$51.6M |
| 4 |
HECA
Hedgeye Capital Allocation ETF
HECA
|
+$43.6M |
| 5 |
First Trust Rising Dividend Achievers ETF
RDVY
|
+$37.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.4M |
| 2 |
iShares S&P 100 ETF
OEF
|
+$31.2M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$29.4M |
| 4 |
iShares iBonds 2026 Term High Yield and Income ETF
IBHF
|
+$25.4M |
| 5 |
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
|
+$24.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.12% |
| 2 | Financials | 4.47% |
| 3 | Industrials | 3.2% |
| 4 | Consumer Discretionary | 3.13% |
| 5 | Communication Services | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
ACV Auctions
ACVA
$1.35B
| $55K | ﹤0.01% |
+12,977
| New | +$85K |
|
|
ONL
3852
Orion Office REIT
ONL
$161M
| $55K | ﹤0.01% |
25,700
+6,015
| +31% | +$13.9K |
|
3853
Immunic
IMUX
$217M
| $54K | ﹤0.01% |
+4,850
| New | +$43.4K |
|
3854
Vuzix
VUZI
$218M
| $54K | ﹤0.01% |
23,261
-262
| -1% | -$715 |
|
3855
OFS Capital
OFS
$48.6M
| $53K | ﹤0.01% |
15,040
| – | – |
|
3856
SELLAS Life Sciences
SLS
$2.31B
| $53K | ﹤0.01% |
12,435
| – | – |
|
3857
BRC Inc
BRCC
$215M
| $52K | ﹤0.01% |
66,906
-2,640
| -4% | -$2.22K |
|
3858
Beyond Meat
BYND
$214M
| $52K | ﹤0.01% |
+73,408
| New | +$58.7K |
|
|
NRO
3859
Neuberger Real Estate Securities Income Fund Inc
NRO
$188M
| $52K | ﹤0.01% |
18,239
+110
| +0.6% | +$329 |
|
3860
Acco Brands
ACCO
$399M
| $50K | ﹤0.01% |
16,643
-97
| -0.6% | -$365 |
|
3861
Cricut
CRCT
$1.23B
| $50K | ﹤0.01% |
13,303
| – | – |
|
3862
TMC The Metals Company
TMC
$1.94B
| $50K | ﹤0.01% |
+10,747
| New | +$69.3K |
|
|
CIF
3863
DELISTED
MFS Intermediate High Income Fund
CIF
| $49K | ﹤0.01% |
29,964
+2,500
| +9% | +$4.21K |
|
|
SLI
3864
Standard Lithium
SLI
$594M
| $48K | ﹤0.01% |
14,164
-9,975
| -41% | -$44.7K |
|
3865
Anavex Life Sciences
AVXL
$316M
| $46K | ﹤0.01% |
14,960
-7,100
| -32% | -$30.8K |
|
|
HTZWW
3866
Hertz Global Holdings Warrants
HTZWW
$112M
| $46K | ﹤0.01% |
20,208
-1,795
| -8% | -$4.39K |
|
3867
BitFuFu
FUFU
$217M
| $44K | ﹤0.01% |
22,309
+5,596
| +33% | +$14.5K |
|
3868
Prime Medicine
PRME
$580M
| $43K | ﹤0.01% |
+12,337
| New | +$47K |
|
3869
W&T Offshore
WTI
$555M
| $43K | ﹤0.01% |
12,505
| – | – |
|
|
DHF
3870
BNY Mellon High Yield Strategies Fund
DHF
$175M
| $42K | ﹤0.01% |
17,078
+59
| +0.3% | +$146 |
|
3871
Gevo
GEVO
$391M
| $40K | ﹤0.01% |
14,651
-1,702
| -10% | -$3.52K |
|
|
EU
3872
enCore Energy
EU
$268M
| $36K | ﹤0.01% |
20,195
-171,373
| -89% | -$438K |
|
|
OCCI
3873
OFS Credit Co
OCCI
$74.6M
| $36K | ﹤0.01% |
+12,482
| New | +$47.6K |
|
3874
Altimmune
ALT
$570M
| $35K | ﹤0.01% |
+11,206
| New | +$47.6K |
|
3875
Douglas Elliman
DOUG
$184M
| $34K | ﹤0.01% |
20,798
+5,050
| +32% | +$11.7K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Cambridge Investment Research Advisors held 4,122 positions worth $38.8B, up 2.5% from $37.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cambridge Investment Research Advisors deployed $1.75B of net new capital in Q1 2026, opening 310 new positions and adding to 2,005 existing holdings. Its largest new stake was Hedgeye Capital Allocation ETF: 1,477,836 shares worth $42.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $35.4M trimmed.
- Cambridge Investment Research Advisors's largest Q1 2026 buy was Hedgeye Capital Allocation ETF: 1,477,836 shares worth $42.7M.
- Cambridge Investment Research Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $140M increase.
- Cambridge Investment Research Advisors's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $35.4M.
- Cambridge Investment Research Advisors fully exited Nuveen S&P 500 Buy-Write Income Fund in Q1 2026, selling an estimated $7.82M.
- Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $38.8B portfolio in Q1 2026.
- Cambridge Investment Research Advisors opened 310 new positions and closed 198 in Q1 2026.
- Cambridge Investment Research Advisors's portfolio value rose 2.5% quarter-over-quarter to $38.8B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.